Cipla Q2 Results Today: Net profit up 4% YoY to Rs 1,351 crore, revenue grows 8%

Cipla Q2 FY26 Results: The India business generated Rs 3,146 crore in revenue, up 7 per cent YoY, led by solid traction in core therapies. Cipla’s respiratory brand Foracort retained its No. 1 ranking in the domestic market.